Polymer‐Formulated Nerve Growth Factor Shows Effective Therapeutic Efficacy for Cerebral Microinfarcts

Cerebral microinfarcts represent the most prevalent form of ischemic brain injury in the elderly, particularly among those suffering from dementia, Alzheimer's disease, and vascular risk factors. Despite their commonality, effective treatments have remained elusive. Herein, a novel treatment utilizing a polymer-formulated nerve growth factor capable of crossing the blood-brain barrier is reported, which effectively reduced oxidative stress and neuronal apoptosis, reshaped microglia polarization at infarct sites, and decreased the overall microinfarct burden, leading to notable improvements in behavioral and cognitive functions in a mouse model. This work provides a promising new avenue for the treatment of cerebral microinfarcts and other neurodegenerative diseases.

Authors

Institutions

Publication Details

Journal
Advanced Materials
Published
2024-11-27
DOI
https://doi.org/10.1002/adma.202412843
Citations
3
Primary Topic
Nerve injury and regeneration
Type
article
Field-Weighted Citation Impact
0.80

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Polymer‐Formulated Nerve Growth Factor Shows Effective Therapeutic Efficacy for Cerebral Microinfarcts

Yunfeng Lu, Huanxing Su, Yu‐Qi Feng, Qihai Gong et al.
3 citations
Advanced Materials
Nerve injury and regeneration
0.80
article

Polymer‐Formulated Nerve Growth Factor Shows Effective Therapeutic Efficacy for Cerebral Microinfarcts

Yunfeng Lu, Huanxing Su, Yu‐Qi Feng, Qihai Gong, Jimin Guo, Dajiang Qin, Yicheng Feng, Lihua Hou, Kunyao Xu, Chaoyong Liu, Meng Qin, Yilong Wang, Mo Yang, Lingli Yan
article en
3 citations

Abstract

Cerebral microinfarcts represent the most prevalent form of ischemic brain injury in the elderly, particularly among those suffering from dementia, Alzheimer's disease, and vascular risk factors. Despite their commonality, effective treatments have remained elusive. Herein, a novel treatment utilizing a polymer-formulated nerve growth factor capable of crossing the blood-brain barrier is reported, which effectively reduced oxidative stress and neuronal apoptosis, reshaped microglia polarization at infarct sites, and decreased the overall microinfarct burden, leading to notable improvements in behavioral and cognitive functions in a mouse model. This work provides a promising new avenue for the treatment of cerebral microinfarcts and other neurodegenerative diseases.

Advanced MaterialsVol. 37(3)
Zunyi Medical University (CN), Capital Medical University (CN), University of Macau (MO), Sichuan University (CN), Beijing Tian Tan Hospital (CN), Beijing University of Chemical Technology (CN)
Innovative Research Group Project of the National Natural Science Foundation of China, National Natural Science Foundation of China, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, National Key Research and Development Program of China
Good health and well-being
Openalex Percentile: Top 28%
Nerve injury and regeneration
0.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.